TG Therapeutics Inc — Balance Sheet (NASDAQ:TGTX) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Total assets 625.64 M379.63 M193.57 M329.59 M577.69 M Total liabilities 106.29 M142.48 M134.99 M169.09 M355.33 M Total equity 519.35 M237.15 M58.59 M160.5 M222.36 M Total liabilities & shareholders' equities 625.64 M379.63 M193.57 M329.59 M577.69 M Total debt ————— Net debt —————

Nachrichten

TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line

TG Therapeutics (TGTX) Misses Q4 Earnings Estimates

TG: EPS verfehlt Schätzungen um 0,23 $ - Umsatz besser als erwartet

TG earnings missed by $0.23, revenue topped estimates

Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates

TG Therapeutics faces earnings test as Briumvi growth accelerates

TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q4 Release

BRIUMVI im Fokus: TG Therapeutics stellt Studiendaten auf ACTRIMS-Forum vor

TG Therapeutics presents BRIUMVI data at ACTRIMS forum

TG Therapeutics: B.Riley bestätigt Kaufempfehlung dank starkem Briumvi-Wachstum/n

TG Therapeutics stock maintains Buy rating at B.Riley on strong Briumvi growth

TG Therapeutics stellt neue Daten zu MS-Medikament BRIUMVI auf Fachkongress vor